CYCLOSERINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for cycloserine and what is the scope of patent protection?
Cycloserine
is the generic ingredient in one branded drug marketed by Sanaluz and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are seven drug master file entries for cycloserine. One supplier is listed for this compound.
Summary for CYCLOSERINE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 7 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 130 |
| Clinical Trials: | 131 |
| Patent Applications: | 6,981 |
| What excipients (inactive ingredients) are in CYCLOSERINE? | CYCLOSERINE excipients list |
| DailyMed Link: | CYCLOSERINE at DailyMed |
Recent Clinical Trials for CYCLOSERINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Beijing Chest Hospital | Phase 3 |
| National Medical Center for Infectious Diseases | Phase 3 |
| University of Alberta | Phase 2 |
Medical Subject Heading (MeSH) Categories for CYCLOSERINE
Anatomical Therapeutic Chemical (ATC) Classes for CYCLOSERINE
US Patents and Regulatory Information for CYCLOSERINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanaluz | SEROMYCIN | cycloserine | CAPSULE;ORAL | 060593-001 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
